.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Argus Health
Teva
Julphar
US Department of Justice
Healthtrust
Harvard Business School
Chinese Patent Office
Farmers Insurance
Mallinckrodt

Generated: November 24, 2017

DrugPatentWatch Database Preview

Ethambutol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ethambutol hydrochloride and what is the scope of ethambutol hydrochloride freedom to operate?

Ethambutol hydrochloride
is the generic ingredient in two branded drugs marketed by Sti Pharma Llc, Lupin, Barr, and Akorn, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ethambutol hydrochloride. Fourteen suppliers are listed for this compound.

Pharmacology for ethambutol hydrochloride

Medical Subject Heading (MeSH) Categories for ethambutol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
ETHAMBUTOL HYDROCHLORIDE
ethambutol hydrochloride
TABLET;ORAL076057-001Nov 26, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-003Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Lupin
ETHAMBUTOL HYDROCHLORIDE
ethambutol hydrochloride
TABLET;ORAL078939-001Jun 17, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
ETHAMBUTOL HYDROCHLORIDE
ethambutol hydrochloride
TABLET;ORAL075095-002Nov 30, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin
ETHAMBUTOL HYDROCHLORIDE
ethambutol hydrochloride
TABLET;ORAL078939-002Jun 17, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn
ETHAMBUTOL HYDROCHLORIDE
ethambutol hydrochloride
TABLET;ORAL075095-001Nov 30, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sti Pharma Llc
MYAMBUTOL
ethambutol hydrochloride
TABLET;ORAL016320-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Baxter
Argus Health
Colorcon
Citi
QuintilesIMS
AstraZeneca
Boehringer Ingelheim
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot